# Anand Parikh

> Anand Parikh is the Austin-based co-founder, chair and CEO of Faeth Therapeutics, a clinical-stage biotechnology company built around cancer metabolism. Trained in political science, biology and corporate law, he moved from tech M&A into an early operating role at Virta Health before co-founding Faeth in 2019. His career is a study in crossing disciplines, learning in public and assembling scientific expertise around a contrarian research thesis.

- **Role:** Chair, CEO & Co-Founder at Faeth Therapeutics
- **Organizations:** Faeth Therapeutics, Virta Health, Morrison & Foerster LLP
- **Education:** BA in Political Science and Biology, University of Michigan, JD with a focus on corporate law; coursework at NYU Stern in corporate finance, New York University School of Law
- **Known for:** Co-founded Faeth Therapeutics in 2019., Helped Faeth raise a $20 million seed round in 2022., Built a founding group that included cancer researchers Lewis Cantley, Siddhartha Mukherjee, Karen Vousden, Scott Lowe, Greg Hannon and Oliver Maddocks.

## Career timeline

- **Before 2016** — Began his career as a corporate attorney at Morrison & Foerster, working in technology M&A.
- **2016-2019** — Joined Virta Health as employee number three and worked across finance, legal, fundraising, business development, people operations and regulatory functions.
- **2019** — Co-founded Faeth Therapeutics with Oliver Maddocks and a group of cancer biologists.
- **2022** — Faeth announced a $20 million seed round co-led by Khosla Ventures and Future Ventures.
- **2023** — Faeth in-licensed sapanisertib and established PIKTOR as its lead oral multi-node program.
- **2025** — Faeth initiated a Phase 2 study of PIKTOR in advanced or recurrent endometrial cancer.
- **2026** — Sensei Biotherapeutics acquired Faeth in February; the combined company later adopted the Faeth Therapeutics name, with Parikh serving as chair and CEO.

## Achievements

- Co-founded Faeth Therapeutics in 2019.
- Helped Faeth raise a $20 million seed round in 2022.
- Built a founding group that included cancer researchers Lewis Cantley, Siddhartha Mukherjee, Karen Vousden, Scott Lowe, Greg Hannon and Oliver Maddocks.
- Helped advance Faeth from a founding thesis to clinical-stage programs and a 2026 public-company combination.
- Served as an early cross-functional operator at Virta Health, joining as employee number three.

## Latest updates

- **2026-06** — The combined Sensei-Faeth company changed its name to Faeth Therapeutics; Parikh is listed as chair, CEO and co-founder.
- **2026-05** — The company announced dosing of the first patient in a Phase 1b/2 PIKTOR trial in advanced breast cancer.
- **2026-02** — Sensei Biotherapeutics acquired Faeth in a stock-for-stock transaction accompanied by a $200 million private placement; Parikh joined the combined company's leadership and board.

## Links

- Website: https://www.faeththerapeutics.com/
- LinkedIn: https://www.linkedin.com/in/anandkparikh
- Twitter/X: https://twitter.com/faethtx
- Instagram: https://www.instagram.com/faeththerapeutics/
- Facebook: https://facebook.com/faeththerapeutics/

---

Profile page: https://yespress.io/anand-parikh
Published by YesPress — https://yespress.io
Last updated: 2026-08-27